Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Two-Arm Randomized Study to Characterize Flu-Like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Current Interferon Beta Therapies to BIIB017

NCT01939002 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01939002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01939002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Two-Arm Randomized Study to Characterize Flu-Like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Current Interferon Beta Therapies to BIIB017
Lead sponsor
Biogen
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
November 30, 2015
Enrollment
251 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing multiple sclerosis